AUG 14, 2015 10:28 AM PDT

Kick the Habit

WRITTEN BY: Kerry Evans
Nearly 6 million people die every year from tobacco-related illness, but breaking the addiction is easier said than done.  Current smoking cessation therapies include the nicotine receptor agonist varenicline, the antidepressant bupropion, and various nicotine replacement therapies (gums, patches, and lozenges). However, more effective aids are needed, because only 15-30% of people who use these therapies remain tobacco-free in the long-term.

Tobacco-related illness kills nearly 6 million annually.
One alternative to drug-based therapy is a "nicotine vaccine".     In fact, a number of nicotine vaccines are in clinical trials, but show varied success when compared to placebos.

Researchers at The Scripps Research Institute (TSRI) are taking a different approach.     They knew a number of microorganisms were capable of degrading tobacco waste, and one bacterium, Pseudomonas putida, is extremely good at it.  
 


“The bacterium is like a little Pac-Man”, says Kim Janda, professor of chemistry at TSRI, “it goes along and eats nicotine”.


Non-pathogenic P. putida uses a number of enzymes to degrade nicotine to fumaric acid.  Song Xue, a graduate student at TSRI, investigated the enzyme NicA2 for its safety and efficacy as a smoking cessation drug, and the preliminary data appears quite promising.

When Xue and colleagues combined serum from mouse blood, nicotine, and NicA2, the half-life of nicotine dropped from 2 to 3 hours to between 9 and 15 minutes. On top of that, NicA2 remained stable in serum, produced no toxic metabolites, and proved to be heat stable for up to 3 weeks.  These are all signs that NicA2 could one day help people kick the tobacco habit.



Sources: Journal of the American Chemical Society, The Scripps Research Institute, Tech Times
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
NOV 17, 2019
Health & Medicine
NOV 17, 2019
Acute Flaccid Myelitis and Its Association With Enterovirus D68
Acute flaccid myelitis (AFM), a polio-like infection, caught the attention of physicians in the U.S. during late summer and early fall in 2014. The outbrea...
NOV 17, 2019
Microbiology
NOV 17, 2019
To Maintain Diversity in the Microbiome, Wild Animals Need Their Natural Foods
Bacterial communities can be vital partners to many living organisms, from humans beings to the white-throated woodrat....
NOV 17, 2019
Genetics & Genomics
NOV 17, 2019
A More Precise Version of CRISPR/Cas9 is Created
A more accurate version of Cas9 has been created, reducing the number of off-target effects. It may be better suited for use in gene therapy....
NOV 17, 2019
Immunology
NOV 17, 2019
This is How Your Immune System Responds to Ebola Vaccination
Vaccines to prevent Ebola are still in their infancy, with experimental-only versions being used only in the most dire of instances. In a new study, scient...
NOV 17, 2019
Microbiology
NOV 17, 2019
The Antimicrobial Power of Mucus is Revealed
We produce several liters of mucus every day to cover more than 200 square meters in the human body....
NOV 17, 2019
Microbiology
NOV 17, 2019
Unusual Fungi Found in Marine Environments
Fungal colonies were cultured from samples collected in various marine environments. Image by: Lorna M.Y. Mitchison-Field...
Loading Comments...